Pilot Study of the Safety and Efficacy of Anakinra (Recombinant Human Interleukin-1 Receptor Antagonist) in Heart Failure
Clinical trial NCT01300650 · COMPLETED
Trial details
- NCT number
- NCT01300650
- Sponsor
- Virginia Commonwealth University
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-01
- Primary completion
- 2011-08-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.